GLP-1 injections don't replace habits — but do they need to?

What did @coach_seangraham actually say?

Sean's argument is that GLP-1 medications like semaglutide don't "teach your body how to actually lose fat," and that once you stop them, "the weight goes back on, the cravings come back." He adds that users end up with "even less muscle than when you started," leaving them with a slower metabolism and stuck "starving yourself just to maintain" the weight lost. His prescription: gym, routine, lifestyle change, enjoyable food.

That's a coherent fitness-coach argument. Some of it is grounded in real evidence. Some of it oversimplifies what's actually happening pharmacologically, and the framing that these drugs do almost nothing useful beyond a temporary number on the scale isn't quite honest to the research.

Does the science back this up?

Partially, yes. Weight regain after stopping GLP-1 medications is real and well-documented. But the claim that muscle loss is uniquely catastrophic with these drugs needs more nuance than Sean gives it.

The STEP 1 trial extension (Wilding et al., 2022, Diabetes, Obesity and Metabolism) followed participants after they stopped semaglutide. Within a year, they regained about two-thirds of the weight lost. Hunger and cravings did return. That part of Sean's claim holds up. Where it gets complicated is muscle loss. A 2023 analysis by Ida et al. in the Journal of Cachexia, Sarcopenia and Muscle found that GLP-1 users do lose lean mass, but this is broadly true of any significant caloric deficit, not a unique drug side effect. Resistance training during treatment substantially reduces this loss. Sean is right that most people aren't doing that. He's wrong to imply the drugs cause uniquely damaging muscle loss on their own.

What did they get wrong (or right)?

Sean gets credit for the lifestyle point. He's right that GLP-1 medications don't automatically install better habits. They suppress appetite, they don't teach portion awareness or gym consistency. That's not a drug failure, it's just what drugs do versus what behavioral coaching does. Fair point.

But "you go back to your old lifestyle, eating the foods that you really enjoy" frames normal eating as the enemy, which is a bit rich coming from a coach who also says you should "eat foods that you enjoy." That contradiction sits in the same 90-second video.

The bigger problem is the claim that these medications don't teach your body "how to actually lose fat." That's not how fat loss works pharmacologically or physiologically. Semaglutide activates GLP-1 receptors in the hypothalamus, reducing appetite signaling. The body is losing fat through a real caloric deficit. It's not a trick. The deficit is just easier to sustain while on the drug. Framing this as fake fat loss is inaccurate.

The metabolism claim, that stopping leaves you with a "low metabolism" worse than before, is plausible but overstated. Total energy expenditure does drop with weight loss generally (Leibel et al., 1995, New England Journal of Medicine), but there's no strong evidence the drop is meaningfully worse after GLP-1 use than after any other caloric restriction method.

What should you actually know?

GLP-1 medications are not a permanent fix if used in isolation, and Sean is right to say so. But they're also not the metabolic trap he describes. The honest picture is more complicated.

• Weight regain after stopping is real. The STEP 1 extension data is clear on this. If you stop the drug without changing underlying habits, most of the weight comes back within 12 months.
• Muscle loss happens on any significant diet. It is not uniquely caused by GLP-1 drugs. Resistance training during treatment is the evidence-based mitigation, and that part of Sean's message is correct.
• Appetite suppression is not "fake" fat loss. The caloric deficit is real. The fat lost is real. The drug lowers the difficulty of maintaining that deficit, it doesn't manufacture a false result.
• Behavioral support alongside medication improves long-term outcomes. A 2023 review by Rubino et al. in Nature Medicine noted that combining GLP-1 therapy with structured lifestyle intervention produced better weight maintenance than either alone.
• These are prescription medications for a reason. Anyone considering them should have that conversation with a licensed clinician, not base the decision on a TikTok, in either direction.